The influenza virus RNA-dependent RNA polymerase is capable of initiating replication, but mainly catalyzes abortive RNA synthesis in the absence of viral and host regulatory factors. Previously, we reported that IREF-1/MCM stimulates de novo-initiated replication reaction by stabilizing an initiated replication complex through scaffolding between the viral polymerase and nascent cRNA to which MCM binds. In addition, several lines of genetical and biochemical evidences suggest that viral nucleoprotein (NP) is involved in successful replication. Here, using cell-free systems, we have shown the precise stimulatory mechanism of the virus genome replication by NP. Stepwise cell-free replication reactions revealed that exogenously added NP free of RNA activates the viral polymerase during promoter escape, while it is incapable of encapsidating the nascent cRNA. However, we found that a previously identified cellular protein, RAF-2p48/NPI-5/UAP56 facilitates replication reaction-coupled encapsidation as an NP molecular chaperone. These demonstrate that replication of the virus genome is followed by its encapsidation by NP in collaboration with its chaperone.
INTRODUCTION
The genome of influenza type A viruses consists of eight-segmented and single-stranded RNAs of negative polarity. Transcription from the viral RNA genome (vRNA) is initiated using the oligonucleotide containing the cap-1 structure from cellular pre-mRNAs as primer, whereas genome replication is primer-independent and generates full-length vRNA through cRNA (full-sized complementary copy of vRNA) (reviewed in (17) ). Generally, each viral DNA or RNA genome is not present as naked form but as a complex with viral basic proteins. The influenza virus genome exists as ribonucleoprotein (termed vRNP) complex with nucleoprotein (NP), one of viral basic proteins, and viral RNA-dependent RNA polymerases consisting of three subunits (PB1, PB2, and PA). NP binds single-stranded RNA without sequence specificity and is required for maintaining the RNA template in an ordered conformation suitable for viral RNA synthesis and packaging into virions (6, 23, 34) . In the case of Mononegaviridae, nonsegmented and negative-stranded RNA viruses, it is proposed that the nucleocapsid (N) protein forms a trimeric complex with the viral RNA polymerase large (L) protein and phosphoprotein (P) to form a replicase complex to produce the progeny viral genome with concomitant encapsidation of nascent RNA by N protein, and encapsidation is mediated by the chaperone activity of P protein (2, 7, 14, 24) . In the case of influenza virus, it is also postulated that NP might regulate the viral polymerase function and encapsidate the virus genome through its interaction with PB1 and/or PB2 (1, 23) . Genetic analyses suggest that NP participates in the replication process (15) .
Recently, it is also shown that NP saturated with ssDNA, resulting in lacking its RNA binding activity, stimulates the virus genome replication from a model template without primer (18) . It is possible that NP stimulates the virus genome replication possibly through the interaction with the viral polymerase in an RNA binding activity-independent manner. Moreover, the in vitro cRNA synthesis using infected cell extracts as enzyme source depends on a supply of NP free of RNA (27) . This finding has been interpreted as that NP prevents the premature termination of RNA synthesis possibly by binding to nascent RNA chains, that is, encapsidating them.
Based on these, it could be hypothesized that NP facilitates the virus genome replication by both RNA binding-and viral polymerase binding-dependent mechanisms. It is proposed that encapsidation is initiated by successive targeting of exogenous NP monomer to a replicating RNA through the interaction between NP and the viral polymerase, which is distinct from replicative enzyme bound to the 5'-end of nascent RNA (1, 8, 11, 22) , and then additional NP molecules are subsequently recruited by the NP-NP oligomerization (3, 23) . It is also reported that nascent cRNA is degraded by host cellular nucleases unless it is stabilized by newly synthesized viral RNA polymerases and NP (33) . However, the precise molecular mechanisms about the virus genome replication and encapsidation by NP are yet unclear.
The cRNA synthesis occurs from incoming vRNA in infected cells, but vRNP complexes isolated from virions by themselves hardly synthesize cRNA (9) . Thus, it was reasonable to examine whether a host factor(s) and/or a viral factor(s) are required for the replication process. We reconstituted a cell-free virus genome replication system with virion-associated vRNP and nuclear extracts prepared from uninfected HeLa cells (9) . Using biochemical fractionation and complementation assays, we identified influenza virus replication factor (IREF)-1 that enabled the viral polymerase to synthesize full-sized cRNA. Otherwise, the viral RNA polymerase produces mainly abortive short RNA chains in the absence of IREF-1. IREF-1 was found to be identical with a minichromosome maintenance (MCM) heterohexamer complex.
IREF-1/MCM stabilizes replicating polymerase complexes by promoting the interaction between the nascent cRNA and the PA subunit.
Here, we examined the molecular function of NP in influenza virus genome replication using the previously established cell-free virus genome replication system using virion-associated vRNP. Exogenously added NP free of RNA stimulated the virus genome replication with MCM in an additive manner. Further, we found that NP activates the viral polymerase during its transition from initiation to elongation to synthesize the unprimed full-length cRNA, but NP by itself is incapable of encapsidating the nascent cRNA. However, we found that RAF-2p48/NPI-5/UAP56/BAT1, which was identified as a host factor for activation of viral RNA synthesis (16) , is required for the encapsidation of nascent cRNA with exogenously added NP free of RNA and the stimulation of elongation process of virus genome replication. We observed that the level of the virus genome replication was decreased in infected cells when the expression of the RAF-2p48/UAP56 gene was knockdown by siRNA-mediated gene silencing. Collectively, we would propose the NP-and host factor-dependent mechanism of the virus genome encapsidation in concert with its replication.
MATERIALS AND METHODS
Biological materials. vRNP was prepared from purified influenza A/Puerto Rico/8/34 virus as previously described (28) . For the expression of His-tagged NP (His-NP), we cloned the open reading frame corresponding to the NP gene into pET14b.
Rabbit polyclonal antibody against NP was generated by immunization of 2 month-old female rabbit with His-NP protein. HeLa cells were grown in Dulbecco's modified
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum.
Preparation of recombinant proteins. His-tagged recombinant proteins were prepared and purified according to the manufacturers' protocol. In addition, to remove the bacterial RNA possibly bound to NP, we treated recombinant proteins with RNase A before purification, and washed them with a buffer containing 1 M NaCl.
Recombinant RAF-2p48/UAP56 was prepared from GST-tagged RAF-2p48/UAP56 by PreScission protease (GE healthcare) digestion. Purified proteins were stored in a buffer containing 50 mM HEPES-NaOH (pH 7.9), 300 mM KCl, 20% glycerol, and 1 mM DTT at -80ºC until use. Recombinant MCM complex was prepared as previously described (9) . These purified recombinant proteins were separated by SDS-PAGE and visualized by staining with Coomassie brilliant blue in Fig. 1A . Fig. 1C (Fig. 1D) . We observed that authentic NP free of RNA purified from virions by CsCl glycerol density gradient centrifugation (5, 34) also possesses the stimulatory activity as well as recombinant NP (data not shown). We used, as the enzyme source, the vRNP containing authentic NP that is bound to the template RNA.
Cell
Thus, it is quite likely that RNA-free NP but not template-bound NP is required for the de novo virus genome replication. The RNA synthesis level varied among segments as previously described (9) . For instance, the segments 1, 2, and 3 were hardly replicated compared with other segments. The reason for this variation in cRNA synthesis is unknown presently.
NP facilitates the promoter escape of the viral RNA polymerase.
Previously, we demonstrated that MCM does not enhance the frequency of the replication initiation, but rather makes a nonproductive viral polymerase override the step for abortive synthesis. To examine whether NP is involved in the initiation reaction of the virus genome synthesis, we carried out a limited elongation assay, in which UTP is omitted from the reaction mixture and the RNA polymerase pauses at the first adenine residue on the template. The expected lengths of limited elongation products are 12 nt for segments 1, 3, and 7; 13 nt for segments 5 and 8; 14 nt for segment 6; 18 nt for segment 4; and 19 nt for segment 2. Since we detected the comparable amount of each RNA product in the absence or presence of exogenous NP (Fig. 1E) , it is concluded that NP does not stimulate the initiation reaction as MCM does not (9) . Thus, NP may be required for a step(s) post the initiation and the early elongation steps, in which short cRNAs are synthesized.
To examine whether NP stimulates the transition of the viral polymerase from initiation to elongation, that is, the promoter escape of the viral polymerase, unprimed limited elongation assays were first performed in the absence of UTP, and elongation reactions were restarted by the addition of UTP (Fig. 1F) . MCM (0.5 pmol) or exogenous NP (3 pmol) was also added either before or after the limited elongation. (Fig. 1E) and the viral polymerase could not transit from initiation to elongation in the absence of NP (Fig. 1F) , it is possible that NP stimulates elongation complexes during the promoter escape of the viral polymerase as does MCM (9) . The cell-free virus genome replication reaction was also carried out ( Fig. 1G ) in the presence of MCM (lane 2; 0.5 pmol) or NP (lane 3; 3 pmol) with a low concentration of UTP to slow down the reaction and synthesize a ladder of nascent cRNA chains in order to examine the length of elongated nascent cRNA chains. We found that comparable amounts of cRNA with shorter length (~100 nt) are synthesized in the presence of either MCM or NP. In contrast, the amount of longer one (>100 nt) stimulated by MCM was more than that by NP (Fig. 1G , compare lane 2 with lane 3).
Therefore, it is quite likely that MCM promotes the elongation process more effectively than NP, possibly due to the weak interaction of exogenously added NP with long nascent cRNA as described later. Taken together, it is strongly suggested that NP stimulates the promoter escape of the viral polymerase as does MCM. Previous reports showed that the target of MCM is PA (9), whereas that of NP is PB1 and PB2 (1).
Therefore, it is possible that the replication stimulation mechanism by NP and MCM are distinct each other.
The encapsidation of newly synthesized virus genome by NP.
Previously, we proposed that MCM stimulates the virus genome replication by acting as a scaffold between nascent cRNA chains and the viral polymerase during the promoter escape of the polymerase (9). Since NP has both RNA and viral polymerase binding activities, it should be speculated that NP also functions as a scaffold between newly synthesized RNA and the viral polymerase as does MCM. To address this, we tried to pull down the replicated cRNA chains associated with His-tagged either MCM or NP using Ni-NTA resin ( Fig. 2A) . The cell-free virus genome replication reaction was carried out in the presence of equal molar amount of MCM (lanes 1 and 3) or NP (lanes 2 and 4) with a low concentration of UTP in order to examine the length of co-purified RNA as described in Fig. 1E . As shown in input lanes, MCM stimulated the elongation process more effectively than NP as shown in Fig. 1E ( Fig subsequently NP is recruited through NP-NP oligomerization (3, 23) . In our cell-free system, we found that exogenous NP interacts with shorter cRNA (Fig. 2A, lane 4) without the addition of soluble viral polymerases, which could bind to the 5'-end of the nascent RNA and be a target of NP. It might be explained that the primary targeting of NP to the nascent RNA easily occurs since there is no RNA target other than the nascent RNA in our system. However, it is worthwhile to note that encapsidation of longer nascent cRNA by NP was not achieved, when NP was simply added to the system (lane 4). This raises a question how newly synthesized virus genome is encapsidated with NP free of RNA.
NP recognizes the phosphodiester backbone of ssRNA in a specific sequence-independent manner. We used, as the enzyme source, the vRNP containing authentic NP, which is bound to the template RNA. Thus, it is reasonably hypothesized that newly synthesized cRNA chains remain associated with the template RNP possibly by partial hybridization of the nascent cRNA with template vRNA and/or the interaction of nascent cRNA with template-bound authentic NP instead of exogenous NP. To address this, we immunopurified the template-bound authentic NP of vRNP in the presence of exogenous His-NP using anti-NP antibody (Fig. 2B) . The length of RNA products associated with authentic NP or both authentic NP and exogenous His-NP (lane 3) was clearly distinct from that interacting with only exogenous His-NP (lane 4). From these results, it is assumed that the nascent cRNA product is hardly encapsidated with exogenous NP since the nascent cRNA tends to interact with template-bound NP more than exogenous NP and might partially hybridize with the template.
The encapsidation with NP mediated by RAF-2p48/ UAP56. As shown in Fig. 2 , it is assumed that some factor(s) may be missing in the encapsidation of nascent cRNA products with exogenous NP. Previously, RAF-2p48/UAP56/BAT1 (hereafter, designated RAF-2p48/UAP56) belonging to the DExD-box family of ATP-dependent RNA helicase (13) , also reported as NPI-5 (20) , was identified as a host factor that binds to NP and stimulates influenza virus RNA synthesis from exogenously added model vRNA templates (16) and is involved in splicing of cellular pre-mRNAs and messenger RNP maturation of cellular and viral transcripts (4, 25, 29) . RAF-2p48/UAP56 binds to NP free of RNA but not NP-RNA complex, and facilitates NP-RNA complex formation as a molecular chaperone for NP. Therefore, it was proposed that RAF-2p48/UAP56 is involved in the arrangement of NP on the template. However, its precise roles, including the requirement for encapsidation process, have been yet uncovered. Thus, we tried to examine whether RAF-2p48/UAP56 facilitates the encapsidation of newly synthesized RNA with exogenous NP (Fig. 3) . We found that long nascent cRNA was encapsidated with exogenous NP by the addition of RAF-2p48/UAP56 (compare lane 4 (in the presence of RAF-2p48/UAP56) with lane 3
(in the absence of RAF-2p48/UAP56)). The ATP-dependent RNA unwinding activity of RAF-2p48/UAP56 was not required for the encapsidation of nascent chains since the encapsidation occurred in the presence of ATPS, which is a nonhydrolyzable analog of ATP (data not shown). Therefore, we propose a model that RAF-2p48/UAP56
facilitates the formation of RNP complexes by co-replicationally transferring exogenous NP to the nascent cRNA chain but not remodeling secondary structures of template and newly synthesized cRNA by its potential RNA helicase activity (see Fig. 5 ).
Furthermore, RAF-2p48/UAP56 stimulated the elongation activity of the viral polymerase possibly due to facilitating the encapsidation of nascent cRNA (Fig. 3, lane 2). It is speculated that the co-replicational encapsidation of nascent cRNA by NP may prevent the premature termination of RNA synthesis by avoiding a secondary structure of nascent RNA, which is hypothesized as one of causative factors in the termination process of other RNA polymerases (10, 27) . Therefore, it is possible that the encapsidation of the nascent RNA with exogenous NP mediated by RAF-2p48/UAP56
increases the processivity of the viral polymerase through avoiding inappropriate secondary structures of nascent cRNA. (Fig. 4A and 4B) . We carried out quantitative primer extension assays with appropriate primers specific for each vRNA and m/cRNA of segment 5 ( Fig.   4C and 4D ). We confirmed that the product corresponding to cRNA was not found from a fraction bound with oligo(dT) cellulose (data not shown). This result showed that the accumulation of vRNA and cRNA was reduced and delayed in RAF-2p48/UAP56 knockdown cells compared with control cells (Fig. 4C , lanes 1-7 and 14-20, and Fig. 4D ). The same results were obtained for other segments (data not shown). It is proposed that nascent cRNA is degraded unless it is encapsidated with viral RNA polymerase and NP (33) . In addition, the results in Fig. 3 and the previous report (16) demonstrated that RAF-2p48/UAP56 stimulates the viral polymerase activity.
Involvement of RAF-2p48/UAP56 in influenza virus
Thus, RAF-2p48/UAP56 might be involved in the virus genome replication and encapsidation in infected cells. We also found that the level of NP mRNA in RAF-2p48/UAP56 knockdown cells decreased to 15% in control cells at 3 hpi (Fig. 4C , lanes 15 and 18, and Fig. 4E ). In contrast, the comparable amounts of NP mRNA were found in both control and RAF-2p48/UAP56 knockdown cells at 6 and 9 hpi (Fig. 4C,   lanes 16, 17, 19 , and 20) since the amount of vRNA template enough for the viral mRNA synthesis might be accumulated at 6 and 9 hpi but the replication activity was reduced and delayed in RAF-2p48/UAP56 knockdown cells. To confirm the effect of RAF-2p48/UAP56 on viral transcription, we utilized cycloheximide (CHX), a potent protein synthesis inhibitor (Fig. 4C, lanes 8-13 and 21-26, and Fig. 4E) . A previous report showed that CHX suppresses viral protein synthesis and thereby leads to degradation of replicated viral RNA but not mRNA since newly vRNP formation was repressed (33) . Therefore, we could examine the amount of viral mRNA synthesized from incoming vRNP independent of the level of vRNA accumulation in the presence of CHX (Fig. 4C, lanes 8-13, and Fig. 4E ). The level of NP mRNA in RAF-2p48/UAP56
knockdown cells was reduced to 70% in control cells in the presence of CHX at 3 hpi (Fig. 4C, lanes 21 and 24, and Fig. 4E ). Therefore, it is likely that the reduction of viral mRNA synthesis in RAF-2p48/UAP56 knockdown cells is mainly due to the decrease of vRNP accumulation in the absence of CHX, although RAF-2p48/UAP56
has a stimulatory role in the viral transcription possibly by arrangement of NP on template and/or the nuclear export-competent messenger RNP formation (25) . To rule out the possibility that the reduction of vRNA and cRNA synthesis was caused by the reduction of viral protein synthesis, we carried out a viral model replicon assay (19, 30) , in which active vRNP complexes are reconstituted with PB1, PB2, PA, and NP, and the model vRNA encoding luciferase gene as described in Materials and Methods (Fig. 4F) .
With this system, we could examine the viral polymerase activity independent of the expression level of viral proteins since viral proteins were expressed from plasmids under the control of cellular RNA polymerase II promoter in this assay. Fig. 4F showed that the vRNA, cRNA, and viral mRNA synthesis were decreased in RAF-2p48/UAP56 knockdown cells compared with that in control cells even in the presence of comparable amounts of NP in both cells. We found that NP synthesized in RAF-2p48/UAP56 knockdown cells migrates differently from that in control cells (Fig.   4F ). Previous reports showed that NP is modified by phosphorylation (23) and its N-terminal region is digested by caspase (35) , but the involvement of RAF-2p48/UAP56 in these is not known at present.
It is well known that NP is one of proteins responsible for the virus genome replication (15, 18, 27, 33) . Recently, it is reported that ubiquitination of NP regulates the virus genome replication (12) . It is proposed that the soluble viral polymerase might act as a replicative enzyme in trans, but transcription occurs from template-bound viral polymerase in cis (8) . In this study and recent reports (9, (31) (32) (33) , the de novo cRNA synthesis is found from template-bound viral polymerase, thus it could be explained that the soluble viral polymerase might have the stimulatory activity but is not completely essential for the synthesis of nascent cRNA. The viral nuclear export protein (NEP/NS2) is also involved in the accumulation level of vRNA and cRNA (26) . stimulates the co-replicational encapsidation of newly synthesized cRNA with exogenous NP, thereby increasing the processivity of the viral polymerase.
